A Study to Assess Efficacy and Safety of ASP1941 in Diabetic Patients With Renal Impairment
Clinical trial NCT01316094 · COMPLETED
Trial details
- NCT number
- NCT01316094
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-18
- Primary completion
- 2012-11-28
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.